In-vitro Toxicology Testing Market Size Is Anticipated to Reach USD 30.9 Billion By 2027 : Grand View Research Inc.

March 24 09:12 2020
In-vitro Toxicology Testing Market Size Is Anticipated to Reach USD 30.9 Billion By 2027 : Grand View Research Inc.

Grand View Research, Inc. – Market Research And Consulting.
According to report published by Grand View Research,The global in-vitro toxicology testing market size was estimated at USD 15.3 billion in 2019 and is expected to register a CAGR of 9.2% over the forecast period.

The global in-vitro toxicology testing market size is anticipated to reach USD 30.9 billion by 2027 and is projected to register a CAGR of 9.2% over the forecast period, according to a new report by Grand View Research, Inc. The new paradigm shift in toxicity testing of animal models toward computational methods such as silico models to interpret toxicity pathway data, drives the demand for in-vitro toxicology testing. These methods provide cost and time efficiency and enhance safety assessment.

Several governments are taking measures to minimize animal-based test models, forming conducive government policies, and providing funds to support in-vitro models. These factors are expected to create ample growth opportunities for the market. For instance, in November 2019, the U.S. National Institute for Environmental Health Sciences planned to provide funds to small companies for the development of engineered 3D culture or organotypic culture models (OCM) in-vitro systems.

With advancements in high throughput screening, biological screening, and chemical synthesis, the number of publicly available databases containing data related to toxicity; absorption, distribution, metabolism, and excretion (ADME); pharmacovigilance; and drug screening has expanded rapidly. This has enabled scientists to access vast information for toxicity profiling, thereby spurring revenue generation in this market.

U.K. in-vitro toxicology testing market size, by technology, 2016 - 2027 (USD Million)

Request a sample Copy of the In-vitro Toxicology Testing Market Research Report @

Key Takeaways Of The Report :

  • Growing application of 3D-spheroid-cultures, particularly for nanoparticle toxicity testing, resulted in the dominance of the cell culture technology segment in 2019

  • Omics technology is anticipated to register lucrative growth as RNA sequencing and shotgun proteomics are increasingly used for a more comprehensive understanding of the effects of toxicants

  • The high usage rate of cellular assays with advancements in cell-based technologies, including label-free detection and high-content screening, has contributed to the dominance of the cellular assays segment in 2019

  • Systemic toxicology emerged as the leading application segment in 2019 as it plays a key role in risk assessment during drug development procedures. For instance, toxicity testing of systemic immunosuppressive drugs and systemic corticosteroids is important during the development of drugs for ocular inflammatory disease

  • Pharmaceutical industry dominated the in-vitro toxicology testing market in 2019 as toxicological testing is a prerequisite step for drug development

  • Stringent government regulations regarding animal usage for toxicity analysis in North America have led to an increased adoption rate of in-vitro models. Hence, North America dominated the global market in 2019

  • The Asia Pacific region is anticipated to witness the fastest growth rate over the forecast period due to increasing initiatives by public agencies to encourage acceptance of non-animal test models

  • Abbott, Thermo Fisher, Agilent Technologies, GE Healthcare, Bio-Rad, and Merck KGaA are some of the key players operating in the market.

Global in-vitro toxicology testing market share, by end use, 2019 (%)

Have Any Query? Ask Our Experts @

Grand View Research has segmented the global in-vitro toxicology testing market on the basis of technology, method, application, end use, and region:

In-vitro Toxicology Testing Technology Outlook (Revenue, USD Million, 2016 – 2027)

  • Cell Culture Technology

  • High Throughput Technology

  • Molecular Imaging

  • OMICS Technology

In-vitro Toxicology Testing Method Outlook (Revenue, USD Million, 2016 – 2027)

  • Cellular Assay

  • Biochemical Assay

  • In Silico

  • Ex-vivo

In-vitro Toxicology Testing Application Outlook (Revenue, USD Million, 2016 – 2027)

  • Systemic Toxicology

  • Dermal Toxicity

  • Endocrine Disruption

  • Ocular Toxicity

  • Others

In-vitro Toxicology Testing End-use Outlook (Revenue, USD Million, 2016 – 2027)

  • Pharmaceutical Industry

  • Cosmetics & Household Products

  • Diagnostics

  • Chemical Industry

  • Food Industry

In-vitro Toxicology Testing Regional Outlook (Revenue, USD Million, 2016 – 2027)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • U.K.

  • Asia Pacific

    • China

    • Japan

  • Latin America

    • Brazil

  • Middle East and Africa (MEA)

    • South Africa

Browse Related Report :

3D Cell Culture Market :

Nucleic Acid Isolation And Purification Market :

About Grand View Research

Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: United States